Oncolys Strikes Deal with Kagoshima Univ. to Develop COVID-19 Therapy

June 22, 2020
Oncolys BioPharma said on June 19 that it has entered into a patent assignment agreement with Kagoshima University for compounds identified by the university to commence the development of novel COVID-19 therapies. A research group led by Prof. Masanori Baba,...read more